Online citations, reference lists, and bibliographies.
← Back to Search

Mitochondrial‐targeted Nitroxides Disrupt Mitochondrial Architecture And Inhibit Expression Of Peroxiredoxin 3 And FOXM1 In Malignant Mesothelioma Cells

B. Cunniff, K. Benson, Jason K. Stumpff, Kheng Newick, P. Held, D. Taatjes, J. Joseph, B. Kalyanaraman, N. Heintz
Published 2013 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Malignant mesothelioma (MM) is an intractable tumor of the peritoneal and pleural cavities primarily linked to exposure to asbestos. Recently, we described an interplay between mitochondrial‐derived oxidants and expression of FOXM1, a redox‐responsive transcription factor that has emerged as a promising therapeutic target in solid malignancies. Here we have investigated the effects of nitroxides targeted to mitochondria via triphenylphosphonium (TPP) moieties on mitochondrial oxidant production, expression of FOXM1 and peroxiredoxin 3 (PRX3), and cell viability in MM cells in culture. Both Mito‐carboxy‐proxyl (MCP) and Mito‐TEMPOL (MT) caused dose‐dependent increases in mitochondrial oxidant production that was accompanied by inhibition of expression of FOXM1 and PRX3 and loss of cell viability. At equivalent concentrations TPP, CP, and TEMPOL had no effect on these endpoints. Live cell ratiometric imaging with a redox‐responsive green fluorescent protein targeted to mitochondria (mito‐roGFP) showed that MCP and MT, but not CP, TEMPOL, or TPP, rapidly induced mitochondrial fragmentation and swelling, morphological transitions that were associated with diminished ATP levels and increased production of mitochondrial oxidants. Mdivi‐1, an inhibitor of mitochondrial fission, did not rescue mitochondria from fragmentation by MCP. Immunofluorescence microscopy experiments indicate a fraction of FOXM1 coexists in the cytoplasm with mitochondrial PRX3. Our results indicate that MCP and MT inhibit FOXM1 expression and MM tumor cell viability via perturbations in redox homeostasis caused by marked disruption of mitochondrial architecture, and suggest that both compounds, either alone or in combination with thiostrepton or other agents, may provide credible therapeutic options for the management of MM. J. Cell. Physiol. 228: 835–845, 2013. © 2012 Wiley Periodicals, Inc.
This paper references
Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.
F. Reale (1987)
10.1002/IJC.2910570220
Mechanism of inhibition of fadu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride
D. Rideout (1994)
10.1111/J.1432-1033.1994.TB19985.X
Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase.
T. Friedrich (1994)
10.1016/0003-4975(95)00045-M
Characteristics of nine newly derived mesothelioma cell lines.
H. Pass (1995)
10.1006/GYNO.1996.0026
Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
A. Manetta (1996)
10.1016/S0167-7799(97)01068-8
Selective targeting of bioactive compounds to mitochondria.
M. Murphy (1997)
10.1074/jbc.274.12.7936
Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species*
Andrew C. Lee (1999)
10.1074/jbc.M009093200
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
G. F. Kelso (2001)
10.1016/S0169-409X(01)00125-9
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells.
J. Modica-Napolitano (2001)
Selective targeting of a redoxactive ubiquinone tomitochondria within cells
GF Kelso (2001)
10.1038/ncb836
Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism
D. Bota (2002)
10.1152/PHYSREV.00018.2001
Free radicals in the physiological control of cell function.
W. Dröge (2002)
10.1152/AJPLUNG.00038.2003
Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis.
A. Shukla (2003)
10.1152/PHYSIOLGENOMICS.00058.2004
A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression.
J. E. Conour (2004)
10.1128/MCB.24.11.4696-4709.2004
An Extracellular Signal-Regulated Kinase 1- and 2-Dependent Program of Chromatin Trafficking of c-Fos and Fra-1 Is Required for Cyclin D1 Expression during Cell Cycle Reentry
P. Burch (2004)
10.1074/jbc.M312846200
Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators*
G. Hanson (2004)
10.1016/j.febslet.2004.06.045
Fine‐tuning the hydrophobicity of a mitochondria‐targeted antioxidant
J. Asin-Cayuela (2004)
10.1016/J.FREERADBIOMED.2005.04.016
Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide.
Anuradha Dhanasekaran (2005)
10.1152/AJPCELL.00607.2004
Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth.
W. Koopman (2005)
Title Raf / MEK / MAPK signaling stimulates the nuclear translocationand transactivating activity of FOXM 1 c
R. Y. M. Ma (2005)
10.1007/BF01952109
Mitochondrial distribution and inheritance
K. Berger (1996)
10.1242/jcs.01657
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c
R. Y. M. Ma (2005)
10.1016/J.CBI.2006.07.008
Disruption of mitochondrial redox circuitry in oxidative stress.
Dean P. Jones (2006)
10.1083/jcb.200606005
Oxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery
T. Phalen (2006)
10.1002/cyto.a.20198
Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts
W. Koopman (2006)
10.1110/ps.051734306
Re‐engineering redox‐sensitive green fluorescent protein for improved response rate
M. Cannon (2006)
10.1074/jbc.M608268200
Reactive Oxygen and Targeted Antioxidant Administration in Endothelial Cell Mitochondria*
Y. O’Malley (2006)
Cell signaling. H2O2, a necessary evil for cell signaling.
S. Rhee (2006)
10.1126/SCIENCE.1130481
H2O2, a Necessary Evil for Cell Signaling
S. Rhee (2006)
Reactive oxygen and targeted antioxidant administration in endothelial cellmitochondria
B Pandit (2006)
10.1074/jbc.M607279200
Mitotic Phosphorylation of Dynamin-related GTPase Drp1 Participates in Mitochondrial Fission*
Naoko Taguchi (2007)
10.1016/J.BBCAN.2006.08.006
FoxM1: at the crossroads of ageing and cancer.
J. Laoukili (2007)
10.1038/nrc2223
The emerging roles of forkhead box (Fox) proteins in cancer
S. S. Myatt (2007)
10.4049/jimmunol.178.3.1835
High Concentration of Antioxidants N-Acetylcysteine and Mitoquinone-Q Induces Intercellular Adhesion Molecule 1 and Oxidative Stress by Increasing Intracellular Glutathione1
T. Mukherjee (2007)
10.1038/NCHEMBIO0607-349
Molecular imaging of hydrogen peroxide produced for cell signaling.
Evan W. Miller (2007)
10.1038/NCHEMBIO871
Molecular imaging of hydrogen peroxide produced for cell signaling
Evan W. Miller (2007)
High concentration of antioxidantsN - acetylcysteine andmitoquinone - Q induces intercellular adhesionmolecule 1 and oxidative stress by increasing intracellular glutathione
MP Murphy (2007)
High concentration of antioxidantsNacetylcysteine andmitoquinoneQ induces intercellular adhesionmolecule 1 and oxidative stress by increasing intracellular glutathione
TK Mukherjee (2007)
10.1128/MCB.00387-08
Anaphase-Promoting Complex/Cyclosome-Cdh1-Mediated Proteolysis of the Forkhead Box M1 Transcription Factor Is Critical for Regulated Entry into S Phase
H. Park (2008)
10.4161/cc.7.17.6580
FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner
J. Laoukili (2008)
10.1016/j.devcel.2007.11.019
Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.
A. Cassidy-Stone (2008)
10.1016/j.freeradbiomed.2008.03.011
Redox-based regulation of signal transduction: principles, pitfalls, and promises.
Y. Janssen-Heininger (2008)
10.1016/j.freeradbiomed.2007.12.036
A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria.
J. Trnka (2008)
10.1111/j.1755-148X.2008.00451.x
The reactive oxygen‐driven tumor: relevance to melanoma
L. Fried (2008)
FoxM 1 is degraded at mitotic exit in a Cdh 1 - dependent manner
AC Lee (2008)
FoxM 1 is degraded at mitotic exit in a Cdh 1dependent manner
J Laoukili (2008)
10.1016/j.freeradbiomed.2009.05.026
The cell cycle is a redox cycle: linking phase-specific targets to cell fate.
W. Burhans (2009)
10.1371/journal.pone.0005592
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
U. Bhat (2009)
10.1042/BJ20081386
How mitochondria produce reactive oxygen species
M. Murphy (2008)
10.1042/BJ20091541
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling.
A. G. Cox (2010)
10.1021/bi900558g
Redox potential and peroxide reactivity of human peroxiredoxin 3.
A. G. Cox (2009)
10.1042/BJ20090242
Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins.
A. G. Cox (2009)
10.1073/pnas.0904875106
A hyperfused mitochondrial state achieved at G1–S regulates cyclin E buildup and entry into S phase
K. Mitra (2009)
10.1038/emboj.2009.239
FoxM1, a critical regulator of oxidative stress during oncogenesis
H. Park (2009)
Howmitochondria produce reactive oxygen species
SS Myatt (2009)
10.1111/j.1365-2796.2010.02268.x
Redox sensing: orthogonal control in cell cycle and apoptosis signalling
D. P. Jones (2010)
10.1016/j.ctrv.2009.11.006
Forkhead box M1 transcription factor: a novel target for cancer therapy.
Zhiwei Wang (2010)
10.1073/pnas.1003428107
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
F. Weinberg (2010)
10.1016/j.tibs.2010.04.002
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes.
R. Hamanaka (2010)
10.1371/journal.pone.0013131
Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity
M. Millard (2010)
10.1016/j.mam.2010.02.008
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
S. Ralph (2010)
Forkhead boxM 1 transcription factor : A novel target for cancer therapy
F Weinberg (2010)
10.1089/ars.2011.3969
Mitochondria-targeted small molecule therapeutics and probes.
Robin A. J. Smith (2011)
10.1016/j.taap.2009.11.028
Oxidative stress and oxidative damage in chemical carcinogenesis.
J. Klaunig (2011)
10.4161/cc.10.19.17735
FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy
Bulbul Pandit (2011)
10.1016/j.freeradbiomed.2010.12.036
Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic triphenylmethanes.
Xu Zhang (2011)
10.1007/s00401-011-0930-z
Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration
B. Oettinghaus (2012)
10.1089/ars.2010.3284
High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission.
T. Yu (2011)
10.1161/CIRCULATIONAHA.110.014506
Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus
S. Shenouda (2011)
10.1089/ars.2010.3213
NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats.
Shakil A. Khan (2011)
10.1016/j.bbabio.2010.08.010
The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression.
R. Díaz-Ruíz (2011)
10.1016/j.bcp.2012.01.027
Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes.
S. Qiao (2012)
10.1016/j.bbamcr.2011.11.003
Multitasking in the mitochondrion by the ATP-dependent Lon protease.
S. Venkatesh (2012)
10.1016/j.tibs.2012.02.004
Mitochondrial quality control: an integrated network of pathways.
Fabian Fischer (2012)
10.1089/ars.2011.4414
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.
Subash C. Gupta (2012)
10.1371/journal.pone.0039404
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick (2012)
10.1089/ars.2011.4085
Mitochondrial regulation of cell cycle and proliferation.
V. G. Antico Arciuch (2012)
10.1096/fj.11-196543
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
J. Rehman (2012)
10.1158/0008-5472.CAN-11-3928
Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
G. Cheng (2012)
10.1016/j.freeradbiomed.2011.09.030
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.
B. Kalyanaraman (2012)
10.1155/2012/593838
Energy and Redox Homeostasis in Tumor Cells
Marcus Fernandes de Oliveira (2012)
10.1242/jcs.099234
Mitochondria and cell signalling
S. Tait (2012)



This paper is referenced by
10.3389/fendo.2021.660095
Mitochondrial Fission Protein 1: Emerging Roles in Organellar Form and Function in Health and Disease
Ugochukwu Ihenacho (2021)
10.3390/cancers13051138
Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma
M. Schiavello (2021)
10.1242/jcs.226084
Motor proteins at the mitochondria–cytoskeleton interface
(2021)
10.1091/mbc.E19-07-0413
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
M. Black (2020)
10.1089/ars.2019.7752
Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.
E. Elko (2019)
10.1093/jb/mvz058
Dynamic regulation of subcellular mitochondrial position for localized metabolite levels.
Haya Alshaabi (2019)
10.3760/CMA.J.ISSN.1003-9279.2019.06.004
Up-regulation of peroxiredoxin 3 by high-risk human papillomavirus in cervical cancer cells
Xiao-juan Sun (2019)
10.1134/S0006297919020019
Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis
M. Sharapov (2019)
10.1016/B978-0-12-816485-3.00011-8
Use of delivery technologies to manipulate mitochondrial metabolism
Wing‐Fu Lai (2019)
10.1161/ATVBAHA.117.310605
Hyperoxia Causes Mitochondrial Fragmentation in Pulmonary Endothelial Cells by Increasing Expression of Pro-Fission Proteins
Cui Ma (2018)
10.1074/jbc.RA117.001469
Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation
Kathleen A. Boyle (2018)
10.18632/oncotarget.23171
Mitochondrial dysfunction activates lysosomal-dependent mitophagy selectively in cancer cells
T. Biel (2017)
10.1016/j.redox.2017.12.012
Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies
B. Kalyanaraman (2017)
10.1074/jbc.RA118.003044
Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future
G. Cheng (2018)
10.1002/dneu.22519
To mdivi‐1 or not to mdivi‐1: Is that the question?
George Smith (2017)
10.1021/acs.chemrev.7b00042
Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
J. Zielonka (2017)
Mitochondrial dynamics in the radiation response of cancer cells
M. Parker (2017)
10.17077/ETD.O00K-INM5
Investigating the effects of structural modification of alkyl triphenylphosphonium compounds on mitochondrial uncoupling and accumulation
Chaitanya A. Kulkarni (2017)
10.1016/j.ajps.2017.05.006
Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective
Z. Wang (2017)
10.1515/revneuro-2016-0041
Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases
Sonia Esposito (2017)
10.1089/ars.2015.6266
Dissecting Redox Biology Using Fluorescent Protein Sensors.
M. Schwarzländer (2016)
Mitochondria-targeted analogs of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells Running title : Enhanced antiproliferative effects of Mito-Metformin
G. Cheng (2016)
10.1158/0008-5472.CAN-15-2534
Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
G. Cheng (2016)
10.1091/mbc.E16-05-0286
AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion
B. Cunniff (2016)
10.1016/j.freeradbiomed.2015.05.002
Malignant mesothelioma as an oxidative stress-induced cancer: An update.
S. H. Chew (2015)
10.2174/0929867322666150729114036
Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs.
A. Lyakhovich (2015)
10.1371/journal.pone.0121837
Lipophilic Triphenylphosphonium Cations Inhibit Mitochondrial Electron Transport Chain and Induce Mitochondrial Proton Leak
J. Trnka (2015)
10.1007/s00432-015-1916-3
The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells
Lianqin Li (2015)
10.1371/journal.pone.0127310
Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma
B. Cunniff (2015)
10.1016/j.canlet.2015.05.016
Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Gang Cheng (2015)
10.2174/1381612820666140305230546
Regulation and quantification of cellular mitochondrial morphology and content.
K. Tronstad (2014)
10.1016/j.redox.2014.01.021
Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine
B. Cunniff (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar